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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Brief pressure overload of the left ventricle reduced myocardial infarct
(MI) size in rabbits has been previously reported. Its effects in other species are not known. This
study investigates effects of pressure overload and the role of adenosine in rats in this study.
Methods: MI was induced by 40-minute occlusion of the left anterior descending coronary artery
followed by 3-hour reperfusion. MI size was determined by triphenyl tetrazolium chloride stain-
ing. Brief pressure overload was induced by two 10-minute episodes of partial snaring of the
ascending aorta. Systolic left ventricular pressure was raised 50% above the baseline value.
Ischemic preconditioning was elicited by two 10-minute coronary artery occlusions.
Results: The MI size (mean  standard deviation), expressed as percentage of area at risk, was
significantly reduced in the pressure overload group as well as in the ischemic preconditioning
group (17.4 3.0% and 18.2 1.5% vs. 26.6 2.4% in the control group, p< 0.001). Pretreatment
with 8-(p-sulfophenyl)-theophylline (SPT), an inhibitor of adenosine receptors, did not signifi-
cantly limit the protection by pressure overload and ischemic preconditioning (18.3  1.5%have no conflicts of interest relevant to this article.
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Role of adenosine in pressure overload in rats 757and 18.2  2.0%, respectively, p < 0.001). SPT itself did not affect the extent of infarct
(25.4  2.0%). The hemodynamics, area at risk and mortality were not significantly different
among all groups of animals.
Conclusion: Brief pressure overload of the left ventricle preconditioned rat myocardium against
infarction. Because SPT did not significantly alter MI size reduction, our results did not support a
role of adenosine in preconditioning by pressure overload in rats.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Transient reversible ischemia renders myocardium resistant
to subsequent prolonged ischemiaereperfusion injury and
reduces myocardial infarct (MI) size.1 The phenomenon of
ischemic preconditioning also attenuates postischemic
arrhythmia2 and improves recovery from myocardial stun-
ning.3 Although first reported in dogs,1 ischemic pre-
conditioning has been found in other species, including
pigs,3e5 sheep,6 rabbits,7,8 and rats.9 This laboratory finding
has also been applied in cardiac surgery to protect human
myocardium.10e12 In order to avoid ischemic insult, several
nonischemic maneuvers, including rapid cardiac pacing,13
heat stress,14 pharmacological administration,4 and vol-
ume overload,15,16 have been developed to mimic pre-
conditioning effects.
We previously reported brief pressure overload of the left
ventricle by two 10-minute episodes of partial snaring of the
ascending aorta preconditionedmyocardium and significantly
reduced MI size.7,8 The experiments in both of our reports
were done in rabbits. It is not certain whether pressure
overload preconditioning is a universal phenomenon and
protects other species or not.Compared toother animals, rats
have species difference in ischemic preconditioning.9,17,18 Liu
andDowney9 reported that, although three 5-minute cycles of
preconditioning significantly limited MI size in rats, one
5-minute cycle of preconditioning did not significantly
decrease MI size. They concluded that the threshold for pre-
conditioning was higher in rats.9 Although ATP-sensitive po-
tassium channels are important mediators of ischemic
preconditioning protection in most other animals,16,19 Grover
et al17 reported that ischemic preconditioning in isolated rat
heartswas not affected by glibenclamide, an inhibitor of ATP-
sensitive potassium channels.17 Liu and Downey9 also
demonstrated that glibenclamide did not significantly affect
MI size reduction by ischemic preconditioning in rats. These
observations suggest species differences in ischemic pre-
conditioning between rats and other species.
Although adenosine plays an important role in ischemic
preconditioning in most animals,4,16 its role is not consis-
tent in rats. Although Reid et al20 reported that adminis-
tration of adenosine receptor agonist significantly reduced
MI size in rats, Li and Kloner18 demonstrated that intrave-
nous infusion of adenosine did not significantly decrease MI
size in rats. Administration of 8-(p-sulfophenyl)-theophyl-
line (SPT), a nonselective inhibitor of adenosine receptors,
did not significantly affect the protection of ischemic pre-
conditioning in their report.18 The role of adenosine in
ischemic preconditioning is controversial in rats.
In one report, we showed that SPT did not significantly
affect MI size reduction by pressure overload in rabbits. Wesuggested that pressure overload protected myocardium
independent of the activation of adenosine receptors.7 The
role of adenosine in preconditioning by pressure overload in
rats is not known. Therefore, we conducted this study to
investigate the effects of pressure overload and the role of
adenosine in rats. We chose rats as experimental animals
because species difference9,17,18 and a controversial role of
adenosine18,20 in ischemic preconditioning protection have
been reported in rats.
Materials and methods
This study was approved by the Animal Experiment Com-
mittee of Taipei Veterans General Hospital. Animals used in
this study were cared for humanely in accordance with the
Guide for the care and use of laboratory animals. 21
Animal preparation
SpragueeDawley rats weighing 200e250 g were anes-
thetized by intraperitoneal pentobarbiturate (40 mg/kg).
After tracheotomy, animals were intubated and ventilated
with a ventilator (Harvard Apparatus, Natick, MA, USA) with
a tidal volume of 0.5e1.5 mL and respiratory rate of
95e105 breaths/minute. Descending abdominal aorta was
cannulated for arterial pressure monitoring. Arterial pres-
sure was measured using a Statham P23 pressure transducer
coupled to a pressure processor amplifier (Gould In-
struments, Cleveland, OH, USA). Electrocardiography leads
were placed on limbs. After median sternotomy, the heart
was exposed. A 4-0 silk suture was passed around the
proximal part of left anterior descending coronary artery.
The ends of silk suture were threaded through a small vinyl
tube to form a snare. A ribbon tape was passed around the
ascending aorta. A microtip-manometer (Millar, Houston,
TX, USA) was inserted into the left ventricle to measure left
ventricular pressure. Arterial pressure, heart rate, elec-
trocardiography, and left ventricular pressure were recor-
ded on a pressurized ink-chart recorder (Gould Instruments)
and on a personal computer with a waveform data analysis
software (AcqKnowledge; Biopac System, Goleta, CA, USA).
The body temperature was maintained at 37 C by heating
pads throughout the experiment.
Experimental protocol
After hemodynamics were stable for 30 minutes, rats were
randomly allocated to six groups (Fig. 1). Group 1 received
no intervention. Group 2 received brief left ventricular
pressure overload by partial snaring of the ribbon tape
Figure 1 The experimental protocol. All rats underwent 40-minute coronary artery occlusion (CAO) and 3-hour reperfusion (CAR)
after different treatments. In the treatment period, Group 1 received no intervention, whereas Group 2 received two 10-minute
left ventricular pressure overload (LVPO) by partial snaring of the ascending aorta, and Group 3 received ischemic preconditioning
by two 10-minute coronary artery occlusions. An inhibitor of adenosine receptors, 8-(p-sulfophenyl)-theophylline (SPT), was
intravenously administered in the remaining three groups. Then, Group 4 received left ventricular pressure overload as Group 2,
Group 5 received ischemic preconditioning as Group 3, and Group 6 received no intervention.
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pressure 50% above the baseline value for 10 minutes. Two
episodes of pressure overload were done. Group 3 received
ischemic preconditioning by two episodes of 10-minute
coronary artery occlusion. Group 4 received intravenous
infusion of SPT (7.5 mg/kg; Research Biochemicals Inc.,
Natick, MA, USA) 10 minutes prior to left ventricular pres-
sure overload as in Group 2. Group 5 received intravenous
infusion of SPT 10 minutes prior to ischemic preconditioning
as in Group 3. Group 6 received intravenous infusion of SPT
for 10 minutes. Ten minutes after that above treatments, a
40-minute coronary artery occlusion was done by pulling
the snare around the left anterior descending coronary
artery, which was then fixed by clamping the vinyl tube
with a mosquito clamp. The performance of successful
occlusion was verified by observing the development of ST-
segment elevation and changes in the QRS complex on
electrocardiography, and cyanotic change of myocardium in
the occluded area. After the 40-minute coronary artery
occlusion, the snare was released for reperfusion for 3
hours. No antiarrhythmic agents were given at any time.
Arterial pressure, heart rate, electrocardiography, and left
ventricular pressure were recorded simultaneously and
continuously throughout experiments, including baseline
(prior to treatment), treatment period, 40-minute coronary
artery occlusion, and 3-hour reperfusion.
Determination of area at risk and MI size
At the end of the experiments, a 2000 U dose of heparin was
administered. The heart was rapidly excised and placed on
a perfusion apparatus. The methods for Evans blue dye
perfusion have been previously reported.4,7,8 Briefly, the
left anterior descending coronary artery was ligated at the
site of previous occlusion. The ascending aorta was can-
nulated (distal to the sinus of Valsalva) and perfused with
1% Evans blue dye. After perfusion was completed, the atria
and right ventricular free wall were removed. The leftventricle plus septum was then cut into six or seven
transverse slices, which were incubated at 37 C in 1% tri-
phenyl tetrazolium chloride solution in phosphate buffer
(pHZ 7.4) for 20 minutes to visualize MI (area unstained by
triphenyl tetrazolium chloride). The slices were weighed
and fixed in a 10% formalin solution for 24 hours. The basal
surfaces were photographed. Images were traced with a
digitizer to calculate both the area-at-risk (AAR), identified
by Evans blue dye exclusion, and the MI area. The AAR and
MI area of each heart slice were calculated from planim-
etry. The percentage in area of AAR and MI in each heart
slice was then multiplied by the weight of each slice to
determine the weights of AAR and MI in that heart slice.
Total weights of AAR and MI were then calculated and
summed for the entire left ventricle plus septum. AAR was
reported as percentage of the left ventricle plus septum,
with MI size as percentage of AAR.
Chemicals
SPTwas dissolved in saline (0.9% NaCl) at a concentration of
7.5 mg/mL; pH was adjusted to 7.4 by adding 0.1 N NaOH.
Exclusion criteria
Rats with AAR <10% of left ventricular weight and rats
exhibiting SeT segment shift on electrocardiography during
pressure overload period were excluded.
Statistical analysis
All values are expressed as mean  standard deviation.
Hemodynamic variables were analyzed by a one-way anal-
ysis of variance with repeated measures. The difference of
AAR and MI size among groups was analyzed by one-way
analysis of variance. If the analysis of variance results were
significant, a multiple comparison using a post hoc
Table 2 Hemodynamic changes during pressure overload
of the left ventriclea.
Hemodynamics Baseline 1 LVPO Baseline 2 p
Group 2 (LVPO)
MAP 76  6 64  6b 78  4 <0.001
SAP 107  8 81  6b 110  7 <0.001
SLVP 107  8 157  12b 110  7 <0.001
HR 429  71 416  67 437  64 0.778
Group 4 (SPT-LVPO)
MAP 79  6 65  6b 80  6 <0.001
SAP 108  9 78  10b 107  11 <0.001
SLVP 108  9 160  15b 107  11 <0.001
HR 412  72 427  66 438  66 0.710
Data are presented as mean  SD.
Baseline 1 Z baseline prior to left ventricular pressure over-
load; Baseline 2 Z baseline after left ventricular pressure
overload; HR Z heart rate; LVPO Z left ventricular pressure
overload; MAPZmean arterial pressure; SAPZ systolic arterial
pressure; SLVPZ systolic left ventricular pressure; SPTZ 8-(p-
sulfophenyl)-theophylline.
a There was significant change in MAP, SAP, and SLVP during
pressure overload. One-way analysis of variance p < 0.001.
b Multiple comparison p < 0.001, as compared with Baseline 1.
There was no significant change in HR.
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significantly different. The analysis of covariance was per-
formed to evaluate the group difference of MI (expressed as
percentage of the left ventricular weight) with AAR
(expressed as percentage of the left ventricular weight) as
covariates. Differences were considered significant at
p < 0.05.
Results
Mortality and exclusions
Sixty-nine rats were used in this study (Table 1). Four rats
suffered from ventricular fibrillation and died. Another
three rats died of heart failure, which was defined as a
progressive decrease of systolic arterial pressure <
50 mmHg with global left ventricular dilatation and poor
contraction. One rat in Group 2 had electrocardiography
changes during pressure overload period. One rat in Group 5
suffered from bleeding of sternum and hypotension. They
were excluded. The mortality was not significantly
different (p Z 0.968).
Characteristics of brief pressure overload
During pressure overload, systolic left ventricular pressure
increased significantly from 107  8 mmHg to
157  12 mmHg (p < 0.001), and systolic arterial pressure
decreased significantly from 107  8 mmHg to 81  6 mmHg
(p < 0.001) in Group 2 (Table 2). In Group 4, systolic left
ventricular pressure increased significantly from
108  9 mmHg to 160  15 mmHg (p < 0.001), whereas
systolic arterial pressure decreased significantly from
108  9 mmHg to 78  10 mmHg (p < 0.001) during pressure
overload. Thus, systolic left ventricular pressure was raised
50% above the baseline value during the pressure overload
period, causing obvious pressure overload of the left
ventricle in Group 2 and Group 4. There was no significant
change of heart rate during pressure overload period. After
a brief pressure overload, left ventricular pressure, arterial
pressure, and heart rate returned to baseline level.Table 1 Mortality and exclusions.
Group Treatment No. Mortalitya ECG
Changes
during
LVPO
No.
includedVF HF Other
1 Control 12 1 1 0 0 10
2 LVPO 12 1 0 0 1 10
3 IPC 11 0 1 0 0 10
4 SPT-LVPO 11 1 0 0 0 10
5 SPT-IPC 12 1 0 1 0 10
6 SPT-Control 11 0 1 0 0 10
ECG Z electrocardiography; HF Z heart failure;
IPC Z ischemic preconditioning; LVPO Z left ventricular pres-
sure overload; SPT Z 8-(p-sulfophenyl)-theophylline;
VF Z ventricular fibrillation.
a There was no significant difference in mortality. Pearson
Chi-square p Z 0.968.Hemodynamic changes during experiments
The baseline arterial pressure, heart rate, and mean arterial
pressure-heart rate product of the six groups were not
significantly different (Table 3). The treatments prior to
40-minute coronary artery occlusion did not cause any sig-
nificant hemodynamic changes. Except during pressure over-
load of the left ventricle, there was no significant change in
arterial pressure and heart rate throughout the experiment.
The hemodynamic variables among six groups were not
significantly different during experiments.
AAR and MI size analysis
The AAR (expressed as percentage of left ventricular
weight) of the six groups averaged 48.7  1.8% (Group 1),
48.4  2.5% (Group 2), 48.5  2.4% (Group 3), 48.7  1.5%
(Group 4), 47.6  2.2% (Group 5), and 48.2  2.2% (Group 6;
Table 4). The AAR was not significantly different among the
six groups (pZ 0.881). MI size, expressed as percentage of
AAR, was 26.6  2.4% in the control group (Table 4). Pres-
sure overload (Group 2) significantly reduced MI size
(17.4  3.0%, p < 0.001). Ischemic preconditioning (Group
3) also significantly decreased MI size (18.2  1.5%,
p < 0.001). Administration of SPT prior to pressure overload
(Group 4) did not significantly limit the reduction of MI size
(18.3  1.5%, pZ 0.444 vs. Group 2). The MI size reduction
induced by ischemic preconditioning was not significantly
altered by the pretreatment with SPT (Group 5;
18.2  2.0%, pZ 0.994 vs. Group 3). Administration of SPT
itself (Group 6) did not significantly affect MI size
(25.3  2.0%, p Z 0.214 vs. Group 1).
Because AAR is the main determinant of MI size,22 we
performed analysis of covariance with MI size (expressed as
Table 3 Hemodynamic changes during experiments.a
Group Treatment
protocol
No. Baseline 1 Baseline 2 Coronary artery
occlusion
Coronary artery reperfusion
20 min 40 min 1 h 2 h 3 h
MAP (mmHg)
1 Control 10 75  4 77  6 68  5 72  6 73  8 73  7 72  8
2 LVPO 10 76  6 78  4 72  6 73  7 75  8 74  5 73  6
3 IPC 10 78  8 76  6 69  7 77  10 77  11 76  8 72  9
4 SPT-LVPO 10 79  6 80  6 74  5 77  5 76  6 77  5 75  4
5 SPT-IPC 10 78  3 76  4 72  4 77  7 77  9 77  10 73  6
6 SPT-Control 10 77  4 77  7 72  6 77  7 77  5 76  5 73  4
HR (beats/min)
1 Control 10 426  50 439  50 434  51 440  49 454  43 452  54 452  39
2 LVPO 10 429  71 437  64 448  64 441  62 431  63 437  65 434  66
3 IPC 10 438  44 430  42 449  41 439  51 449  41 452  47 444  33
4 SPT-LVPO 10 412  72 438  66 446  81 440  67 435  72 442  71 433  70
5 SPT-IPC 10 453  45 445  44 452  48 449  49 454  35 463  42 461  45
6 SPT-Control 10 430  52 434  71 451  74 450  62 448  64 448  71 446  60
PRP (mmHg  beats/min/1000)
1 Control 10 31.99  4.54 33.76  5.91 29.56  4.52 31.43  4.33 32.95  4.99 33.00  4.89 32.38  4.93
2 LVPO 10 32.48  4.88 34.01  4.67 31.90  4.46 31.91  5.13 32.01  3.58 32.16  4.09 31.33  4.85
3 IPC 10 34.12  4.96 32.54  4.84 30.95  4.03 33.62  6.62 34.15  4.43 34.01  4.10 31.62  3.78
4 SPT-LVPO 10 32.86  7.65 34.88  6.38 33.12  7.22 33.85  5.54 32.98  6.95 33.89  6.52 32.41  6.29
5 SPT-IPC 10 35.33  3.90 33.76  2.92 32.25  3.56 34.25  4.28 34.86  3.72 35.24  4.51 33.56  3.24
6 SPT-Control 10 32.90  4.62 33.57  6.85 32.42  6.82 34.37  5.85 34.43  4.90 33.85  4.80 32.48  4.56
Data are presented as mean  SD.
Baseline 1 Z baseline prior to treatment; Baseline 2 Z baseline after treatment; HR Z heart rate; IPC Z ischemic preconditioning;
LVPOZ left ventricular pressure overload; MAPZ mean arterial pressure; PRPZ mean arterial pressure-heart rate product; SPTZ 8-
(p-sulfophenyl)-theophylline.
a There was no significant change in MAP, HR, and PRP throughout the experiment. There was no significant difference in hemodynamic
variables among six groups of animals during experiments.
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variable and AAR (expressed as percentage of left ventric-
ular weight) as a covariate to evaluate the effect of AAR on
MI size. The data points and the regression line of eachTable 4 Size of area at risk, expressed as percentage of
left ventricle, and size of myocardial infarct, expressed as
percentage of area at riska.
Group Treatment
protocol
No. AAR/LV (%) MI/AAR (%)
1 Control 10 48.7  1.8 26.6  2.4
2 LVPO 10 48.4  2.5 17.4  3.0b,c
3 IPC 10 48.5  2.4 18.2  1.5b,c
4 SPT-LVPO 10 48.7  1.5 18.3  1.5b,c
5 SPT-IPC 10 47.6  2.2 18.2  2.0b,c
6 SPT- Control 9 48.2  2.2 25.3  2.0
Data are presented as mean  SD.
AAR Z area at risk; IPC Z ischemic preconditioning;
LVPO Z left ventricular pressure overload; MI Z myocardial
infarct; SPT Z 8-(p-sulfophenyl)-theophylline.
a The AAR was not significantly different among all groups
(p Z 0.881). There was significant difference in MI size.
One-way analysis of variance p < 0.001.
b Multiple comparisons p < 0.001 versus control group.
c Multiple comparisons p < 0.001 versus SPT-control group.
Other comparisons were not statistically significant.group are shown in Fig. 2. After adjusting MI for AAR,
analysis of covariance showed the regression lines for MI/LV
for Group 1 and Group 6 were not significantly different.
However, the regression lines for MI/LV for Groups 2e5
were all significantly different from Group 1 (p < 0.001).
The results reveal that pressure overload and ischemic
preconditioning reduces MI size in rats and that the pro-
tective effects of pressure overload and ischemic pre-
conditioning in rats are not dependent upon adenosine
receptor activation.
Discussion
We have demonstrated that brief pressure overload of the
left ventricle significantly reduces MI size in rats and
administration of an adenosine inhibitor does not signifi-
cantly limit the protection in this study. Rat hearts develop
more rapid ATP depletion, more severe cell acidosis, and
more rapid loss of mitochondrial respiratory function during
ischemia, compared to ischemic canine hearts.23 Addi-
tionally, rats have greater xanthium oxidase activity and
produce more oxygen radicals than other species.24,25
Glutathione peroxidase, one component of the endoge-
nous antioxidant defense system, is 10 times lower in rat
hearts than in human and porcine myocardium.25 Species
difference in ischemic preconditioning protection between
rats and other animals have been reported.9,17,18,23e25
Figure 2 Myocardial infarct (MI) size was plotted as a function
of area at risk (AAR). Both MI and AAR were expressed as per-
centage of left ventricular (LV) weight. , regression line of
Group 1 (-, MI/LV Z 4.39 þ 0.31  AAR/LV, p Z 0.12,
R2 Z 0.28). , regression line of Group 2 (B,
MI/LV Z 19.65 þ 0.56  AAR/LV, p Z 0.06, R2 Z 0.63). ,
regression line of Group 3 ( , MI/LVZ 3.05 þ 0.22  AAR/LV,
p Z 0.08, R2 Z 0.34). , regression line of Group 4 (,,
MI/LV Z 10.12-0.07  AAR/LV, p Z 0.81, R2 Z 0.01). ,
regression line of group 5 (6, MI/LVZ 11.00þ 0.38 AAR/LV,
p Z 0.03, R2 Z 0.50). , regression line of Group 6 (C,
MI/LVZ 8.65þ 0.03 AAR/LV, pZ 0.85, R2Z 0.005). The slopes
of regression equations of six groups were not significantly
different.
Role of adenosine in pressure overload in rats 761Although fundamental species differences exist, we have
demonstrated for the first time that pressure overload
preconditions rat myocardium and significantly reduces MI
size. More investigation is needed to determine if pressure
overload protection is a universal phenomenon that has
clinical implications in protecting human myocardium.
In human patients, chronic pressure overload results in
left ventricular hypertrophy and is one of the leading cau-
ses of heart failure.26,27 Chronic constriction of the
ascending aorta,28 aortic arch,29 or abdominal aorta30 are
common pressure overload models to induce left ventricu-
lar hypertrophy and heart failure in animal experiments.
Yarbrough et al31 progressively inflated a cuff around the
supracoronary ascending aorta for 4 weeks in a swine model
to investigate the determinants of extracellular matrix
remodeling in left ventricular pressure overload. In contrast
to acute pressure overload for 10 minutes used in our study,
the experiments of most of the previous reports were of
chronic pressure overload for several weeks.
Adenosine is an endogenous purine nucleotide that plays
an important role in protecting against left ventricular hy-
pertrophy and heart failure due to chronic pressure over-
load.32e35 Meyer et al32 reported that the epicardial and
coronary effluent adenosine concentration was significantly
elevated in compensated pressure overload hypertrophy rats
undergoing suprarenal aorta banding for 10 weeks. However,
the increase of adenosine concentration was not observed in
decompensated rats. Liao et al33 reported that administration
of an adenosine analogue, 2-chloroadenosine, significantly
attenuated cardiac hypertrophy and myocardial dysfunction
in transverse aortic constriction mice. SPT eliminated the
antihypertrophic effect of 2-chloroadenosine. Chung et al34demonstrated that chronic adenosine uptake blockade with
dipyridamole treatment increased myocardial adenosine
levels and attenuated detrimental heart chamber remodeling
in pressure overload rats after suprarenal aorta banding. In a
transgenic mouse model, Xu et al35 showed that mice defi-
cient in extracellular adenosine production developed
significantly more myocardial hypertrophy, left ventricular
dilatation, and left ventricular dysfunction after pressure
overload by transverse aortic constriction.
Although adenosine protects against left ventricular
hypertrophy and heart failure in chronic pressure over-
load,32e35 administration of SPT did not significantly limit
the protective effects of acute pressure overload in the
present study. Adenosine is released during brief
ischemia,36 and induces preconditioning to protect
myocardium against subsequent prolonged ischemic
insult.37 In our study, the oxygen and energy demand might
be increased during pressure overload. However, the cor-
onary perfusion might also be increased, because pressure
overload was induced by partial snaring of the ascending
aorta above the orifice of the coronary arteries. The
myocardial ischemia and adenosine release might not
happen during pressure overload, as suggested by only one
of 23 rats in Group 2 and Group 4 developing SeT-segment
shift on electrocardiography during pressure overload
period in this study (Table 1).
There are several limitations in this study. There are
four different subtypes of adenosine receptors. SPT is a
nonselective inhibitor. The effects of specific subtype of
adenosine receptors were not examined. The effects of
pressure overload and SPT on myocardial blood flow were
not determined. The performance of successful coronary
artery occlusion was verified by observing the development
of SeT-segment elevation and changes in the QRS complex
on the electrocardiography, and cyanotic change of
myocardium in the occluded area. No definite myocardial
blood flow data were collected. However, rats have a
limited collateral coronary circulation38 and our model is
comparable to that widely used in experiments on
myocardial ischemia and preconditioning.9,14,17,18,20 The
current study was conducted on anesthetized, open-chest
rats. The acute effects of anesthesia and surgery should
be taken into account when interpreting the results.39
Although the triphenyl tetrazolium chloride technique is
commonly used in MI experiments, the infarct size might
have been underestimated.40
In conclusion, brief pressure overload of the left
ventricle significantly reduced MI size in rats. The MI size
reduction was not significantly altered by the administra-
tion of a nonselective adenosine receptor inhibitor. Our
results did not support a role of adenosine in myocardial
preconditioning by pressure overload in rats. Further
studies are required to investigate the mechanisms and
signal transduction pathways involved.Acknowledgments
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